Breaking Latent Infection: How ORF37/38-Deletion Mutants Offer New Hope against EHV-1 Neuropathogenicity
Viruses · 2024
DOI: 10.3390/v16091472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Yue Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Infectious Disease, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China. Hauptthemen laut MEDLINE: Herpesviridae Infections, Herpesvirus 1, Equid, Vaccines, Attenuated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Special Projects of the Central Government in Guidance of Local Science and Technology Development, he Major Scientific and Technology Special Project of Xinjiang Uygur Autonomous Region, Special Projects of the Central Government in Guidance of Local Science and Technology Development.
Abstract (Originalsprache)
Equid alphaherpesvirus 1 (EHV-1) has been linked to the emergence of neurological disorders, with the horse racing industry experiencing significant impacts from outbreaks of equine herpesvirus myeloencephalopathy (EHM). Building robust immune memory before pathogen exposure enables rapid recognition and elimination, preventing infection. This is crucial for effectively managing EHV-1. Removing neuropathogenic factors and immune evasion genes to develop live attenuated vaccines appears to be a successful strategy for EHV-1 vaccines. We created mutant viruses without ORF38 and ORF37/38 and validated their neuropathogenicity and immunogenicity in hamsters. The ∆ORF38 strain caused brain tissue damage at high doses, whereas the ∆ORF37/38 strain did not. Dexamethasone was used to confirm latent herpesvirus infection and reactivation. Dexamethasone injection increased viral DNA load in the brains of hamsters infected with the parental and ∆ORF38 strains, but not in those infected with the ∆ORF37/38 strain. Immunizing hamsters intranasally with the ∆ORF37/38 strain as a live vaccine produced a stronger immune response compared to the ∆ORF38 strain at the same dose. The hamsters demonstrated effective protection against a lethal challenge with the parental strain. This suggests that the deletion of ORF37/38 may effectively inhibit latent viral infection, reduce the neuropathogenicity of EHV-1, and induce a protective immune response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Animal Infectious Disease, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China.
- CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen 518055, China.
ORCID-Profile: Jian-Hua Liu
Förderung
- the Special Projects of the Central Government in Guidance of Local Science and Technology Development
- he Major Scientific and Technology Special Project of Xinjiang Uygur Autonomous Region
- Special Projects of the Central Government in Guidance of Local Science and Technology Development
- Major Scientific and Technology Special Project of Xinjiang Uygur Autonomous Region
Zitieren
APA
Hu, Y., Zhang, S. Y., Sun, W. C., Feng, Y. R., Gong, H. R., Ran, D. L., Zhang, B. Z., & Liu, J. H. (2024). Breaking Latent Infection: How ORF37/38-Deletion Mutants Offer New Hope against EHV-1 Neuropathogenicity. Viruses. https://doi.org/10.3390/v16091472
Vancouver
Hu Y, Zhang SY, Sun WC, Feng YR, Gong HR, Ran DL, et al. Breaking Latent Infection: How ORF37/38-Deletion Mutants Offer New Hope against EHV-1 Neuropathogenicity. Viruses. 2024. doi:10.3390/v16091472
BibTeX
@article{Hu2024,
author = {Hu, Yue and Zhang, Si-Yu and Sun, Wen-Cheng and Feng, Ya-Ru and Gong, Hua-Rui and Ran, Duo-Liang and Zhang, Bao-Zhong and Liu, Jian-Hua},
title = {Breaking Latent Infection: How ORF37/38-Deletion Mutants Offer New Hope against EHV-1 Neuropathogenicity},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091472}
}
EUVIMED